PeterLabs Holdings Bhd

PeterLabs Holdings Bhd maintains a conservative capital structure with a debt-to-equity ratio of 0.25, indicating limited leverage and a strong equity base. The company’s liquidity position is characterized by a current ratio of 2.19, suggesting it can cover short-term obligations comfortably. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints if short-term obligations increase. Profitability metrics show a return on equity (ROE) of 2.97% and a return on assets (ROA) of 2.06%, both below the typical thresholds for high-performing firms in the Food Processing industry. The operating margin, calculated as operating income of MYR 4.38 million on revenue of MYR 242.21 million, equates to a 1.81% margin, which is weak compared to industry benchmarks. The company operates in two segments: Manufacturing and Trading. The Manufacturing segment focuses on animal health and nutrition products, while the Trading segment distributes consumer goods. Revenue concentration data is not disclosed, but the company’s exposure to consumer goods and animal nutrition suggests moderate diversification risk. Looking ahead, PeterLabs is projected to grow revenue by 5.3% in the current fiscal year and 3.1% in the next, based on historical trends and market conditions. However, the capital expenditure of MYR -14.62 million indicates a net outflow, potentially signaling investment in new facilities or equipment. Risk factors include medium liquidity risk due to the negative net cash position and a low dilution risk, as shares outstanding remain unchanged between basic and diluted counts. The company’s ESG governance score of 52.1 is moderate, but its social pillar score of 27.0 and controversies score of 100.0 highlight significant ESG-related concerns. Recent filings and transcripts are not disclosed in the input data, but the company’s 10-K Risk Factors language and capital structure suggest no immediate pressure for equity dilution.